Glenview Trust’s iShares iBonds Dec 2029 Term Corporate ETF IBDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
510,500
+15,425
+3% +$358K 0.16% 105
2026
Q1
$11.5M Buy
495,075
+123,775
+33% +$2.9M 0.18% 106
2025
Q4
$8.69M Buy
371,300
+39,699
+12% +$930K 0.13% 121
2025
Q3
$7.78M Buy
331,601
+54,515
+20% +$1.27M 0.12% 126
2025
Q2
$6.46M Buy
277,086
+81,250
+41% +$1.87M 0.11% 129
2025
Q1
$4.53M Buy
195,836
+33,600
+21% +$770K 0.09% 148
2024
Q4
$3.7M Buy
162,236
+70,536
+77% +$1.62M 0.07% 156
2024
Q3
$2.16M Buy
91,700
+21,287
+30% +$493K 0.04% 208
2024
Q2
$1.6M Buy
70,413
+60,320
+598% +$1.36M 0.03% 219
2024
Q1
$230K Buy
+10,093
New +$230K ﹤0.01% 438

Other funds holding IBDU

Glenview Trust's IBDU Position: Q2 2026 in Review

Glenview Trust increased its iShares iBonds Dec 2029 Term Corporate ETF (IBDU) stake by 3.1% in Q2 2026, buying an estimated $358K and bringing the position to 510,500 shares worth $11.8M. The position accounts for 0.16% of the portfolio, ranked #105.

Glenview Trust first reported a position in IBDU in Q1 2024 and has held it in 10 quarters since. 386 funds tracked by Wall St. Rank hold IBDU as of Q2 2026.

  • Glenview Trust held 510,500 shares of iShares iBonds Dec 2029 Term Corporate ETF worth $11.8M as of Q2 2026.
  • Glenview Trust bought 15,425 iShares iBonds Dec 2029 Term Corporate ETF shares in Q2 2026, an estimated $358K.
  • iShares iBonds Dec 2029 Term Corporate ETF made up 0.16% of Glenview Trust's portfolio in Q2 2026, its #105 holding.
  • Glenview Trust first reported a position in iShares iBonds Dec 2029 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 386 funds tracked by Wall St. Rank held iShares iBonds Dec 2029 Term Corporate ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.